NDC 17433-9877-01 - ENEMEEZ Plus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17433-9877
- Requested NDC
- 17433-9877-01
- Package NDCs from labels
- 17433-9877-0, 17433-9877-3, 17433-9877-6, 17433-9877-5, 17433-9877-7, 17433-9877-2, 17433-9877-1, 17433-9877-4, 17433-9877-01
- Manufacturer
- Quest Products, LLC | Enemeez LLC DBA Summit Pharmaceuticals
- Effective date
- 2026-06-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ENEMEEZ Plus - Quest Products, LLC | Enemeez LLC DBA Summit Pharmaceuticals | Quest Products, LLC | Enemeez LLC DBA Summit Pharmaceuticals | 2026-06-30 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17433-9877-0 | ENEMEEZ Plus | 5 mL in 1 TUBE | LIQUID | 5 | 22 | |
| 17433-9877-1 | ENEMEEZ Plus | 1 in 1 CONTAINER | LIQUID | 1 | 22 | |
| 17433-9877-2 | ENEMEEZ Plus | 2 in 1 CONTAINER | LIQUID | 2 | 22 | |
| 17433-9877-3 | ENEMEEZ Plus | 30 in 1 CONTAINER | LIQUID | 30 | 22 | |
| 17433-9877-5 | ENEMEEZ Plus | 5 in 1 CONTAINER | LIQUID | 5 | 22 | |
| 17433-9877-6 | ENEMEEZ Plus | 35 in 1 CONTAINER | LIQUID | 35 | 22 | |
| 17433-9877-7 | ENEMEEZ Plus | 6 in 1 CONTAINER | LIQUID | 6 | 22 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17433-9877 | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [QUEST PRODUCTS, LLC] | 20 | Current NDC, Legacy NDC, 7 package rows | 20250216_1670ca59-7275-4ac6-bef4-674a7b24c7b3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17433-9877-0 | ML - Milliliter | 17433-9877 | 2e9b0ac6-919d-4fe2-a8ba-a2b8c95ed351 | 1 | 2018-05-09 |
| 17433-9877-2 | ML - Milliliter | 17433-9877 | 0f3c3df0-f564-4e9a-9b9e-7083e97ea8fe | 1 | 2025-09-12 |
| 17433-9877-3 | ML - Milliliter | 17433-9877 | 53354c2d-cba7-4902-8a17-9cd8f7ede81b | 1 | 2013-02-13 |
| 17433-9877-5 | ML - Milliliter | 17433-9877 | 7b0c7f3e-bcf2-4dd1-b6d2-bb54d55b0209 | 1 | 2022-05-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BENZOCAINE | ACTIVE INGREDIENT | U3RSY48JW5 | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| BENZOCAINE | ACTIVE MOIETY | U3RSY48JW5 | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | ENEMEEZ PLUS (DOCUSATE SODIUM AND BENZOCAINE) LIQUID [ENEMEEZ INC. DBA SUMMIT PHARMACEUTICALS] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-19 | Warnings | PDC6A3C0OX |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lavender | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db520c80-2a2a-5eb1-e053-2995a90a5bb4 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lemon | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db525c63-29fd-2033-e053-2995a90a56b9 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Cetacaine Topical Anesthetic | BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE | Cetylite Industries, Inc. | 9777acbb-8166-4734-9932-dc66b05bfcb5 | 2022-01-17 | Warnings | U3RSY48JW5 |
| Cetacaine Anesthetic | BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE | Cetylite Industries, Inc. | af1773c5-5d5b-4278-b551-30ad2df6d5b5 | 2022-01-17 | Warnings | U3RSY48JW5 |
| KOLORZ TOPICAL ANESTHETIC TRIPLE MINT | BENZOCAINE | DMG AMERICA, LLC | 0f90b227-f938-4e1a-a79e-1967b1a0477e | 2021-10-01 | Warnings | U3RSY48JW5 |
| FIRSTAR Sting Relief Pad | BENZOCAINE | JIANGMEN SHUIZIRUN SANITARY ARTICLES CO., LTD. | 0e491a7a-4204-439f-862d-741cbc0be9fd | 2021-07-06 | Warnings | U3RSY48JW5 |
| Senna Lax | SENNOSIDES 8.6MG | TopCo Associates, LLC | 83aeb90a-ab00-4e26-aa44-5259dce59018 | 2021-04-28 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | Allegiant Health | 9fbe783e-ddd9-445a-852a-00f4ad754880 | 2021-04-20 | Warnings | M007 F05Q2T2JA0 |
| Topcare Stool Softener | DOCUSATE SODIUM | TopCo Associates, LLC | 6f4fddda-4129-4087-b0e4-ababc5558484 | 2021-02-19 | Warnings | M007 F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | Allegiant Health | 30c9ff75-cee4-4632-86fd-acfdf5ee85af | 2020-10-27 | Warnings | M007 F05Q2T2JA0 |
| Stool Softener | MARC GLASSMAN | Marc Glassman, Inc. | 909cd222-d836-416f-aa7d-deb4a0c5a560 | 2020-09-08 | Warnings | M007 F05Q2T2JA0 |
| Senna Lax | SENNOSIDES 8.6MG | Allegiant Health | 94a9c24a-07c3-4535-b810-b7abc9fc5ad5 | 2019-12-11 | Warnings | M007 |
| Laxative Enteric Coated | BISACODYL 5MG | Marc Glassman, Inc. | ec34fc1e-d122-4fa4-859e-e89e3e12edd5 | 2019-09-18 | Warnings | M007 |
| Womens Laxative | BISACODYL | Marc Glassman, Inc. | aeb3c49b-cbf5-4a47-b19c-e77fbb987a49 | 2019-09-17 | Warnings | M007 |
| Fire Out | BENZOCAINE AND MENTHOL | Randob Ltd. | 77ab634e-13d4-4f5f-87c8-73976e65a842 | 2019-04-12 | Warnings | U3RSY48JW5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.